StockData
Kestra Medical Technologies, Ltd. logo

Kestra Medical Technologies, Ltd. (KMTS) stock

KMTSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends April 30
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 14, 2026Score 5/30
$28.62−3.01 (-9.52%)

Close on Nov 12, 2026Market cap $1.70BP/E –Yield –

Kestra Medical Technologies, Ltd. grew revenue 60.7% to $106.73M over the twelve months to Jul 31, 2026. Free cash flow was -$122.79M. At the latest close the market valued the company at $1.70B.

Revenue
$106.73M
+60.7% vs. a year earlier
Operating income
-$143.52M
TTM Q1 2027
Free cash flow
-$122.79M
TTM Q1 2027
EPS, diluted
-$2.67
TTM Q1 2027

Key statistics

Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jul 31, 2026

Valuation

Market cap
$1.70B
P/E ratio
–
Price to sales
15.97
Price to book
–
Dividend yield
–
Free cash flow yield
-7.20%

Fundamentals

Revenue
$106.73M
Net income
-$149.87M
EPS, diluted
-$2.67
Free cash flow
-$122.79M
Diluted shares
59M

Trading

Next earnings
Dec 10, 2026 (estimated, after the close)
Previous close
$31.63
Open
$31.34
Day's range
$28.46 – $31.81
Volume
531,490
Average volume (20 days)
569,986
52-week range
$17.34 – $31.99
RSI (14 days)
49.4
Volatility (1 year)
65.3%
Relative volume
1.33×

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.

PeriodKMTSS&P 500DifferenceKMTS per yearS&P 500 per year
1 month+6.4%-2.7%+9.1 pts
3 months+2.2%-1.7%+4.0 pts
Year to date+7.9%+11.9%−4.0 pts
1 year+6.8%+12.0%−5.2 pts

Four years at a glance

Fiscal years 2023 to 2026 and trailing twelve months, USD

Revenue

$106.73M+60.7% YoY

Gross profit

$57.51M+99.3% YoY

Operating income

-$143.52M

Net income

-$149.87M

EPS, diluted

-$2.67

Free cash flow

-$122.79M
Reported periodTrailing twelve months

Press releases

Releases Kestra Medical Technologies filed with the SEC as exhibits to Form 8-K or 6-K

All press releases and earnings

About Kestra Medical Technologies

Surgical & Medical Instruments & Apparatus

Kestra Medical Technologies, Ltd. is a medical device and digital healthcare company that develops cardiovascular monitoring and therapy technologies. Its primary offering is the Cardiac Recovery System platform, centered on the ASSURE wearable cardioverter defibrillator. The device continuously monitors cardiac rhythms and delivers defibrillation therapy upon detecting life-threatening ventricular arrhythmias. The platform also includes digital engagement applications and clinical workflow software to support care coordination and clinical insights. The company serves healthcare providers, hospitals, and patients who are at elevated risk of sudden cardiac arrest during recovery.

Company profile, executives and history

Kestra Medical Technologies stock: common questions

What is Kestra Medical Technologies's stock price?

KMTS closed at $28.62 on Nov 12, 2026, down 9.52% on the day. Over the past 52 weeks it traded between $17.34 and $31.99.

What is Kestra Medical Technologies's market cap?

Kestra Medical Technologies was worth $1.70B at the close on Nov 12, 2026: the share price times the diluted shares outstanding.

What is KMTS's P/E ratio?

Kestra Medical Technologies lost money over the twelve months to Jul 31, 2026 (diluted EPS -$2.67), so it has no meaningful P/E ratio.

How much revenue does Kestra Medical Technologies make?

Kestra Medical Technologies reported revenue of $106.73M for the twelve months to Jul 31, 2026, up 60.7% from a year earlier.

Does Kestra Medical Technologies pay a dividend?

No. Kestra Medical Technologies has not paid a cash dividend over the last twelve months.

When does Kestra Medical Technologies report earnings next?

Kestra Medical Technologies is expected to report Q2 FY2027 results on Dec 10, 2026, after the close. The date is estimated from its past reporting pattern until the company confirms it.

How has KMTS stock performed over the past year?

Including dividends, KMTS returned +6.8% over the past year, against +12.0% for the S&P 500.

How many KMTS shares are sold short?

4M shares were sold short at the latest FINRA report, 12.30% of the float, or 8.2 days of average trading volume.

Who are Kestra Medical Technologies's competitors?

Companies most similar to Kestra Medical Technologies by business, industry and size include CVRX, TELA, IRMD, BBNX, OBIO.

See a number that looks wrong?